Viewing nowLipyone Tablet 20 mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

MFDS item code 200703052 · Notified 2007.03.09 · Insurance code 671800580
Improvement of hyperlipidemia; prevention of cardiovascular diseases (myocardial infarction, stroke, etc.)
This medication helps reduce the risk of cardiovascular diseases. In particular, it decreases the risk of myocardial infarction, stroke, vascular interventions, and angina in adults with risk factors for coronary heart disease and in patients with type 2 diabetes. Moreover, it lowers the risk of myocardial infarction, stroke, congestive heart failure hospitalizations, and angina in patients with existing coronary heart disease. It is also effective in treating hyperlipidemia, reducing total cholesterol and LDL cholesterol levels in patients with primary and familial hypercholesterolemia, as well as mixed dyslipidemia, and increasing HDL cholesterol, thereby improving serum lipids. Additionally, it can be used as an adjunct for pediatric and adolescent patients who do not fully respond to dietary modifications. This drug is used for the treatment of cardiovascular diseases and hyperlipidemia.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken at any time of day, with or without food. Hyperlipidemia: The recommended initial dose is atorvastatin 10 mg once daily. However, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia: The dose of this medicine is 10 ~ 80 mg once daily. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. Elderly patients: The efficacy and safety in patients aged 70 years and older are generally similar to those in the general adult patient population.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg per day (there are no clinical data on administering doses of this medicine higher than 20 mg in pediatric patients). The dose should be adjusted at intervals of 4 weeks or longer.
This medication may cause muscle-related symptoms, so if severe muscle pain or weakness occurs, or if there are significant increases in blood test results indicating muscle damage, the medication should be stopped immediately. Furthermore, there is a risk of deteriorating kidney function due to severe muscle damage, so patients with renal disease or a history of muscle problems should exercise special caution. This medication can affect liver function; therefore, patients with liver disease or elevated liver enzyme levels should not use it. Women who are pregnant, may become pregnant, or are breastfeeding should not use this medication. It should not be administered to children, especially those under 10 years old. Interactions may occur if this medication is taken with certain drugs, so patients should inform their doctor or pharmacist if they are taking other medications. Regular liver function tests and muscle-related tests should be conducted while on this medication to early identify any adverse signs. Individuals with excessive alcohol intake or a history of liver disease should be particularly cautious when taking this medication, and if they experience symptoms such as muscle pain, malaise, or fever, they should consult a healthcare professional immediately. This medication contains lactose, so patients with lactose intolerance should not take it. Care should be taken when consuming grapefruit juice or when taking specific antibiotics, antifungal medications, or HIV treatments, as adjustments in dosage may be necessary when combined with certain drugs. Keep this medication out of reach of children, and do not store it in a different container than the original.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it must be stored in a tightly sealed container. It is recommended to maintain a temperature between 1 degree and 30 degrees Celsius at room temperature to safely preserve the medication's effectiveness.
White oval film-coated tablet
Domestic: 30 tablets/bottle, 100 tablets/bottle Export: 30 tablets (10 tablets/PTP x 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.